Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Identification of TP53RK-Binding Protein (TPRKB) Dependency in TP53-Deficient Cancers.

Goswami MT, VanDenBerg KR, Han S, Wang LL, Singh B, Weiss T, Barlow M, Kamberov S, Wilder-Romans K, Rhodes DR, Feng FY, Tomlins SA.

Mol Cancer Res. 2019 Aug;17(8):1652-1664. doi: 10.1158/1541-7786.MCR-19-0144. Epub 2019 May 20.

PMID:
31110156
2.

Notch and Cdk5 in Zebrafish Mindbomb Mutant: Co-regulation or Coincidence?

Kanungo J, Goswami MT, Pant HC.

Folia Biol (Praha). 2018;64(2):35-40. Review.

3.

Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancer.

Chakravarthi BVSK, Goswami MT, Pathi SS, Dodson M, Chandrashekar DS, Agarwal S, Nepal S, Hodigere Balasubramanya SA, Siddiqui J, Lonigro RJ, Chinnaiyan AM, Kunju LP, Palanisamy N, Varambally S.

Prostate. 2018 Jun;78(9):693-694. doi: 10.1002/pros.23533. Epub 2018 Apr 10. No abstract available.

PMID:
29744932
4.

miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.

Chakravarthi BVSK, Chandrashekar DS, Agarwal S, Balasubramanya SAH, Pathi SS, Goswami MT, Jing X, Wang R, Mehra R, Asangani IA, Chinnaiyan AM, Manne U, Sonpavde G, Netto GJ, Gordetsky J, Varambally S.

Mol Cancer Res. 2018 Jul;16(7):1125-1137. doi: 10.1158/1541-7786.MCR-17-0230. Epub 2017 Oct 12. Erratum in: Mol Cancer Res. 2018 Jul;16(7):1205-1206.

5.

Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate Cancer.

Chakravarthi BV, Goswami MT, Pathi SS, Dodson M, Chandrashekar DS, Agarwal S, Nepal S, Hodigere Balasubramanya SA, Siddiqui J, Lonigro RJ, Chinnaiyan AM, Kunju LP, Palanisamy N, Varambally S.

Prostate. 2017 Jan;77(1):10-21. doi: 10.1002/pros.23243. Epub 2016 Aug 22. Erratum in: Prostate. 2018 Jun;78(9):693-694.

6.

MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer.

Chakravarthi BV, Goswami MT, Pathi SS, Robinson AD, Cieślik M, Chandrashekar DS, Agarwal S, Siddiqui J, Daignault S, Carskadon SL, Jing X, Chinnaiyan AM, Kunju LP, Palanisamy N, Varambally S.

Oncogene. 2016 Dec 8;35(49):6330-6340. doi: 10.1038/onc.2016.164. Epub 2016 Jun 6.

7.

Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.

Goswami MT, Reka AK, Kurapati H, Kaza V, Chen J, Standiford TJ, Keshamouni VG.

Oncogene. 2016 Apr 14;35(15):1888-98. doi: 10.1038/onc.2015.258. Epub 2015 Jul 6.

8.

Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.

Goswami MT, Chen G, Chakravarthi BV, Pathi SS, Anand SK, Carskadon SL, Giordano TJ, Chinnaiyan AM, Thomas DG, Palanisamy N, Beer DG, Varambally S.

Oncotarget. 2015 Sep 15;6(27):23445-61.

9.

The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.

Chakravarthi BV, Pathi SS, Goswami MT, Cieślik M, Zheng H, Nallasivam S, Arekapudi SR, Jing X, Siddiqui J, Athanikar J, Carskadon SL, Lonigro RJ, Kunju LP, Chinnaiyan AM, Palanisamy N, Varambally S.

Oncotarget. 2014 Aug 30;5(16):6654-69.

10.

Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy.

Reka AK, Goswami MT, Krishnapuram R, Standiford TJ, Keshamouni VG.

Lung Cancer. 2011 May;72(2):154-9. doi: 10.1016/j.lungcan.2011.01.019. Epub 2011 Feb 26. Review.

11.

Supplemental Content

Loading ...
Support Center